Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of WT-1108 tablets in refractory or unexplained chronic cough
CTR20254063Phase 2Active
- Sponsor
- Westan Pharmaceutical
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WT-1108 in refractory chronic cough (RCC), chronic idiopathic cough (CIC), sponsored by Westan Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
WT-1108
03
Conditions
refractory chronic cough (RCC)chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on CTR20254063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254063.